140 related articles for article (PubMed ID: 3224331)
1. Evidence of multifactorial mechanisms in an adriamycin-resistant HL-60 promyelocytic leukemia cell line.
Burres NS; Myers MT; Sartorelli AC
Cancer Biochem Biophys; 1988 Jul; 10(1):47-57. PubMed ID: 3224331
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of an anthracycline-resistant human leukemic cell line.
Bhalla K; Hindenburg A; Taub RN; Grant S
Cancer Res; 1985 Aug; 45(8):3657-62. PubMed ID: 3860286
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships for the induction of differentiation of HL-60 human acute promyelocytic leukemia cells by anthracyclines.
Schwartz EL; Sartorelli AC
Cancer Res; 1982 Jul; 42(7):2651-5. PubMed ID: 6952957
[TBL] [Abstract][Full Text] [Related]
4. Alterations in tyrosine phosphorylation during the granulocytic maturation of HL-60 leukemia cells.
Frank DA; Sartorelli AC
Cancer Res; 1988 Jan; 48(1):52-8. PubMed ID: 2825968
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of some anthracycline antibiotics in an in vivo model for studying drug-induced human leukemia cell differentiation.
Schwartz EL; Brown BJ; Nierenburg M; Marsh JC; Sartorelli AC
Cancer Res; 1983 Jun; 43(6):2725-30. PubMed ID: 6573951
[TBL] [Abstract][Full Text] [Related]
6. Difference between the resistance mechanisms of aclacinomycin- and adriamycin-resistant P388 cell lines.
Dong J; Naito M; Tatsuta T; Seimiya H; Johdo O; Tsuruo T
Oncol Res; 1995; 7(5):245-52. PubMed ID: 8534930
[TBL] [Abstract][Full Text] [Related]
7. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
Goldenberg GJ; Wang H; Blair GW
Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020
[TBL] [Abstract][Full Text] [Related]
8. [Studies on the mechanism of drug resistance in tumor cells and a new antitumor antibiotic].
Tanaka N
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2666-73. PubMed ID: 6210060
[TBL] [Abstract][Full Text] [Related]
9. [Transfection of HL-60 cells with CYP3A5 gene induces drug-resistant phenotype].
Wang T; Chen FY; Gu CH; Zhong H; Teng Y; Ouyang RR
Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):461-4. PubMed ID: 16188140
[TBL] [Abstract][Full Text] [Related]
10. Cross resistance relevance of the chemical structure of different anthracyclines in multidrug resistant cells.
Tapiero H; Nguyen-Ba G; Lampidis TJ
Pathol Biol (Paris); 1994 Apr; 42(4):328-37. PubMed ID: 7808786
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle events associated with the termination of proliferation by cytotoxic and differentiation-inducing actions of 6-thioguanine on HL-60 cells.
Schwartz EL; Blair OC; Sartorelli AC
Cancer Res; 1984 Sep; 44(9):3907-10. PubMed ID: 6589046
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of adriamycin-resistant HL-60 cells which are not defective in the initial intracellular accumulation of drug.
Marsh W; Sicheri D; Center MS
Cancer Res; 1986 Aug; 46(8):4053-7. PubMed ID: 2425939
[TBL] [Abstract][Full Text] [Related]
13. Experimental studies of new anthracyclines: aclacinomycin, THP-adriamycin and ditrisarubicins.
Umezawa K; Kunimoto S; Takeuchi T
Biomed Pharmacother; 1987; 41(5):206-13. PubMed ID: 2444279
[TBL] [Abstract][Full Text] [Related]
14. DMSO-like rapid decrease in c-myc and c-myb mRNA levels and induction of differentiation in HL-60 cells by the anthracycline antitumor antibiotic aclarubicin.
Stöcker U; Schaefer A; Marquardt H
Leukemia; 1995 Jan; 9(1):146-54. PubMed ID: 7845009
[TBL] [Abstract][Full Text] [Related]
15. Alterations in the topoisomerase II alpha gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase II beta enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line.
Harker WG; Slade DL; Parr RL; Feldhoff PW; Sullivan DM; Holguin MH
Cancer Res; 1995 Apr; 55(8):1707-16. PubMed ID: 7712479
[TBL] [Abstract][Full Text] [Related]
16. Evidence for cell cycle phase-specific initiation of a program of HL-60 cell myeloid differentiation mediated by inducer uptake.
Yen A; Albright KL
Cancer Res; 1984 Jun; 44(6):2511-5. PubMed ID: 6327017
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationship between anthracycline-induced differentiation and inhibition of glycoprotein synthesis in Friend erythroleukemia cells.
Schaefer A; Dahle M; Radenz G; Steinheider G; Marquardt H
Leukemia; 1991 Feb; 5(2):95-100. PubMed ID: 2020200
[TBL] [Abstract][Full Text] [Related]
18. Interaction of antileukemia agents adriamycin and daunomycin with sphinganine on the differentiation of human leukemia cell line HL-60.
Yung BY; Luo KJ; Hui EK
Cancer Res; 1992 Jul; 52(13):3593-7. PubMed ID: 1617630
[TBL] [Abstract][Full Text] [Related]
19. Terminal differentiation of the human promyelocytic leukemia cell line, HL-60, in the absence of cell proliferation.
Ferrero D; Tarella C; Gallo E; Ruscetti FW; Breitman TR
Cancer Res; 1982 Nov; 42(11):4421-6. PubMed ID: 6957259
[TBL] [Abstract][Full Text] [Related]
20. Intracellular distribution and pharmacokinetics of daunorubicin in anthracycline-sensitive and -resistant HL-60 cells.
Hindenburg AA; Gervasoni JE; Krishna S; Stewart VJ; Rosado M; Lutzky J; Bhalla K; Baker MA; Taub RN
Cancer Res; 1989 Aug; 49(16):4607-14. PubMed ID: 2545346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
